Geneos Wealth Management’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $34.3K | Sell |
142
-25
| -15% | -$6.03K | ﹤0.01% | 1765 |
|
|
2025
Q1 | $40.7K | Buy |
167
+121
| +263% | +$29.5K | ﹤0.01% | 2023 |
|
|
2024
Q4 | $15.1K | Buy |
46
+3
| +7% | +$986 | ﹤0.01% | 1862 |
|
|
2024
Q3 | $14.4K | Buy |
+43
| New | +$14.4K | ﹤0.01% | 1686 |
|
|
2022
Q1 | – | Sell |
-3
| Closed | -$2K | – | 2761 |
|
|
2021
Q4 | $2K | Sell |
3
-34
| -92% | -$22.7K | ﹤0.01% | 2562 |
|
|
2021
Q3 | $27K | Sell |
37
-10
| -21% | -$7.3K | ﹤0.01% | 1765 |
|
|
2021
Q2 | $31K | Buy |
47
+10
| +27% | +$6.6K | ﹤0.01% | 1696 |
|
|
2021
Q1 | $23K | Hold |
37
| – | – | ﹤0.01% | 1993 |
|
|
2020
Q4 | $21K | Buy |
37
+34
| +1,133% | +$19.3K | ﹤0.01% | 1864 |
|
|
2020
Q3 | $1K | Hold |
3
| – | – | ﹤0.01% | 2489 |
|
|
2020
Q2 | $1K | Buy |
+3
| New | +$1K | ﹤0.01% | 2425 |
|
|
2020
Q1 | – | Sell |
-3
| Closed | -$1K | – | 2483 |
|
|
2019
Q4 | $1K | Hold |
3
| – | – | ﹤0.01% | 2435 |
|
|
2019
Q3 | $1K | Buy |
+3
| New | +$1K | ﹤0.01% | 2367 |
|